Abdel Gaffar Mohammed/X
Sep 7, 2026, 23:56
Abdel Gaffar Mohammed: Treatment Approaches for Different Types of TMA
Abdel Gaffar Mohammed, IM/Rheumatology consultant at KAH, shared a post on X:
“TMA Treatment Lupus-TTP and APS-TMA are treated with combinations of plasma exchange, high-dose glucocorticoids, rituximab, and anticoagulation.
Complement-mediated TMA relies on targeted complement inhibition (eculizumab or ravulizumab) as the cornerstone of therapy.”
Stay updated with Hemostasis Today.
-
Sep 7, 2026, 18:36Richard Kollen: Preventing Deep Vein Thrombosis During Long Flights
-
Sep 7, 2026, 18:34Mahmoud Hashem: Apixaban – Doses According to the Reason for Use
-
Sep 7, 2026, 18:31Julian P. Villacastin: LAAC as a Treatment Option When Long-Term Anticoagulation Is Problematic
-
Sep 7, 2026, 18:29Geoff Stooke: How Hemophilia Led the Massie Family to the Romanovs and Ronald Reagan
-
Sep 7, 2026, 18:27Sam Mbunya: September is Sickle Cell Awareness Month
-
Sep 7, 2026, 18:25David Akande: Things I Wish People Knew About Sickle Cell
-
Sep 7, 2026, 18:24Prachi Bansal: A Small Act of Giving, A Lifelong Lesson in Humanity
-
Sep 7, 2026, 17:27Isaac Okello: From Global Dialogue to Local Impact in Sickle Cell Disease
-
Sep 7, 2026, 17:03Caitlin Raymond: The People With “Golden Blood”